Work

GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast Cancer

Year: 2026

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-8380296/v1

Authors: Joshua Gruber, Bethania Soares dos Santos, Maycon Marção, Ishrat Durdana, Brian Lee, Lavanya Vumma, Felipe Segato-Dezem, Hannah Chasteen, Song Zhang, Cheryl Lewis, Yan Peng, Alexis LeVee, Megan Wong, Joanne Mortimer, Heather McArthur, Philipp Scherer, Jasmine Plummer

Institutions: The University of Texas Southwestern Medical Center, St. Jude Children's Research Hospital, City Of Hope National Medical Center, City of Hope

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: AstraZeneca, Cancer Prevention and Research Institute of Texas, University of Texas Southwestern Medical Center, Ovarian Cancer Research Alliance, National Institutes of Health, National Cancer Institute

Awards: G3605267802, G6361887759, Recruitment of First-Time, Tenure-Track Faculty Members, Molecular mechanisms and therapeutic principles of VISTA+ triple-negative breast cancers, UT Southwestern Medical Center Simmons Comprehensive Cancer Center

OpenAlex ID: W7119481975

Cites:

Cited by: 3

Related to: